// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

A comparison of pirfenidone versus nintedanib for the management of idiopathic pulmonary fibrosis

Marium Naqvi - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Pirfenidone

Neural respiratory drive (NRD) to predict long term mortality after an acute exacerbation of COPD (AECOPD)

Maxime Patout - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Are there geographical differences in the microbiology of pleural infection?

Maged Hassan - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Drug induced interstitial lung disease: a systematic review

Sarah Skeoch - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

N/A

Digital airflow measurement early in treatment course for spontaneous pneumothorax predicting surgical referral

Rob Hallifax - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary spontaneous pneumothorax

N/A

Exposure-response analysis of tezepelumab in patients with severe asthma to guide phase 3 dose selection

Neang Ly - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Tezepelumab

Late Breaking Abstract - Associations of fathers and their offsprings weight gain with non-allergic asthma

Marianne Lnnebotn - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Immuno-allertypes in non-cystic fibrosis bronchiectasis

Pei yee Tiew - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

Microbiology of pleural infection according to setting

Maged Hassan - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Impact of radiological changes on treatment outcome following endoscopic lung volume reduction with coils (LVRC) in patients with advanced emphysema

Konstantina Kontogianni - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Evolving indications and demographics for domiciliary Non-Invasive Ventilation (NIV) at an acute hospital based NIV service

Alana Livesey - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Serum Surfactant Protein D is decreased by oral steroids in asthma but not COPD

Rose-Marie Mackay - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Prednisolone

Results of pre-EDIT; a randomised feasibility trial of Elastance-Directed Intra-pleural catheter or Talc Pleurodesis (EDIT) in malignant pleural effusion

Geoffrey Martin - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Bronchial Thermoplasty Global Registry: One Year Results

Alfonso Torrego - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Qualitative research evaluating patient preferences for a new COPD treatment

Melanie Schroeder - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Corticosteroid-resistant neutrophilic airway inflammation and hyperresponsiveness caused by IL-13

Elizabeth Davies - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Dexamethasone

Determinants of quality of life in bronchiectasis using the quality of life bronchiectasis (QOL-B) questionnaire: data from the EMBARC registry

Eva Polverino - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Participant experiences in TANDEM feasibility pilot

Amy Barradell - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Holistic services for chronic breathlessness in people with advanced disease: a systematic review and meta-analysis

Sophie Miller - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

MIF antagonism restores corticosteroid sensitivity in a murine model of severe asthma

Venkata sita rama raju Allam - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Dexamethasone

Copyright © 2026. QuantiNova All rights reserved